Quantcast

Latest Panitumumab Stories

2009-01-17 10:17:00

With a pre-emptive, prophylactic skin regimen, patients who receive panitumumab for treatment of metastatic colorectal cancer may be able to avoid some of the skin-associated toxicities, according to data presented at the 2009 American Society of Clinical Oncology Gastrointestinal Cancers Symposium in San Francisco.

2009-01-15 16:53:26

Large numbers of patients with advanced colon cancer should not get some of the most advanced drug treatments, a medical society study recommends. Patients whose tumors have certain mutations in a gene called KRAS should not receive drugs that include Erbitux, co-marketed in the United States by Eli Lilly & Co.

2008-12-16 07:00:00

KRAS Biomarker Presents Potential to Personalize Colorectal Cancer Treatment Determining Who Can Benefit from Vectibix(R) THOUSAND OAKS, Calif., Dec.

2008-11-10 18:00:05

QIAGEN N.V. (NASDAQ: QGEN) (FRANKFURT: QIA) today announced the launch of a new test to determine mutations of the K-ras gene. The K-ras gene is mutated in between 35 percent and 45 percent of metastatic colorectal cancer (CRC) patients.

2008-09-24 12:00:00

Bristol-Myers Squibb and ImClone have presented five year data demonstrating an improved survival rate for head and neck cancer patients when receiving Erbitux and radiotherapy.

2008-09-10 15:00:07

TrimGen Corporation, a U.S. molecular diagnostic company focused on developing advanced genetic tests, today announced the release of Mutector II(TM) KRAS kit.

2008-08-04 21:00:07

MISSISSAUGA, ON, Aug. 4 /PRNewswire-FirstCall/ -- YM BioSciences Inc.

2008-07-02 12:01:11

Clarient has launched its new offering, Kras, which has been validated as a laboratory-developed test to be used as a predictive molecular biomarker for patients with colorectal cancer.

2008-07-01 06:00:12

ALISO VIEJO, Calif., July 1 /PRNewswire-FirstCall/ -- Clarient, Inc.

2008-06-30 12:03:15

Takeda Pharmaceutical and Takeda Bio Development Center have submitted a new drug application of anti-cancer agent, panitumumab for the treatment of patients with progressed or relapse colorectal cancer to the Ministry of Health Labour and Welfare in Japan.


Word of the Day
dipsas
  • A serpent whose bite was fabled to produce intense thirst.
The word 'dipsas' comes from a Greek word meaning 'thirst'.